Director/PDMR's Dealing

RNS Number : 0419P

Oncimmune Holdings PLC

05 June 2020

 

Oncimmune Holdings plc

("Oncimmune" or the "Company")

Director/PDMR's Dealing

Oncimmune Holdings plc (AIM: ONC.L),  the leading global immunodiagnostics group , was informed that, on 4 June 2020, dealings in the Company's ordinary shares of £0.01 each in the Company ("Ordinary Shares") by the following Director / PDMRs had occurred:

-  Meinhard Schmidt, Non-Executive Chairman, together with his wife and PCA, Tatiana Schmidt, acquired in aggregate 13,000 Ordinary Shares at a weighted average price of £1.885 per share

-  Tim Bunting, Non-Executive Director, acquired 150,000 Ordinary Shares at a weighted average price of £1.192 per share

-  Adam Hill, Chief Executive Officer, acquired 8,481 Ordinary Shares at a price of £1.179 per share

-  Matthew Hall, Chief Financial Officer, acquired 1,272 Ordinary Shares at a price of £1.179 per share

-  Ron Kirschner, General Counsel and Company Secretary, acquired 1,652 Ordinary Shares at a price of £1.204 per share

Director/PDMR/ PCA	No. of Ordinary Shares acquired	Resulting interest	Resulting % holding
Meinhard Schmidt / Tatiana Schmidt	13,000	31,000	0.05%
Tim Bunting	150,000	2,956,717	4.7%
Adam Hill	8,481	40,913	0.06%
Matthew Hall	1,272	11,935	0.02%
Ron Kirschner	1,652	1,652	0.003%

This announcement, including the notification below, is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Meinhard Schmidt / Tatiana Schmidt
2	Reason for the notification
a)	Position/status	Non-executive Chairman / PCA
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.17	8,000
			£1.21	5,000
d)	Aggregated information
	- Aggregated volume	13,000 shares Weighted average price of £1.885
	- Price
e)	Date of the transaction	4 June 2020
f)	Place of the transaction	London stock exchange, AIM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Timothy Bunting
2	Reason for the notification
a)	Position/status	Non-executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.195	60,000
			£1.19	90,000
d)	Aggregated information
	- Aggregated volume	150,000 shares Weighted average price of £1.192
	- Price
e)	Date of the transaction	4 June 2020
f)	Place of the transaction	London stock exchange, AIM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Adam Mark Hill
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.179	8,481
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	4 June 2020
f)	Place of the transaction	London stock exchange, AIM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Matthew Hall
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Price	Volume
			£117.9	1,272
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	4 June 2020
f)	Place of the transaction	London stock exchange, AIM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Ron Kirschner
2	Reason for the notification
a)	Position/status	General Counsel and Company Secretary
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.204	1,652
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	4 June 2020
f)	Place of the transaction	London stock exchange, AIM

For further information:

Oncimmune Holdings plc

Ron Kirschner, General Counsel and Company Secretary

[e-mail]

 

END

 

 

DSHSSWESLESSEFM